Adding value to real-world data: the role of biomarkers

Area of Science:

• Biomedical data science
• Clinical research methodology
• Translational medicine

Background:

• Real-world datasets (RWD) offer valuable insights into disease progression and treatment efficacy.
• Integrating biomarker data into RWD can elucidate intra-patient variability and clinical outcomes.
• Biomarkers may enable early disease detection, facilitating preventative interventions.

Purpose of the Study:

• To review the benefits and challenges of incorporating biomarker data into real-world datasets.
• To discuss the impact of biomarker data on understanding complex diseases.
• To highlight rheumatoid arthritis as a case study for biomarker integration.

Main Methods:

• Narrative review of existing literature on biomarker data in RWD.
• Analysis of challenges in sample collection, storage, study design, and data interpretation.
• Case study focus on rheumatoid arthritis to illustrate biomarker applications.

Main Results:

• Biomarker data integration enhances mechanistic understanding of disease trajectories.
• Biomarkers can identify early pathologies, potentially preventing disability and improving outcomes.
• Significant challenges in data acquisition, standardization, and analysis must be addressed.

Conclusions:

• Biomarker data in RWD is crucial for advancing mechanistic insights and personalized medicine.
• Overcoming logistical and analytical challenges is key to maximizing the value of biomarker data.
• Biomarker integration holds significant promise for improving patient care in complex diseases such as rheumatoid arthritis.